| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0003 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0008 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.099 | 0.0009 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |